Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Studies show new role for protein in cancer development

27.06.2003


In two groundbreaking papers published in two prestigious journals over the last two months, University of Southern California researchers have provided evidence of two previously unknown functions for a protein that is central to the transcription of genes. Both papers shed light on the role this protein-called TATA-binding protein, or TBP-may play in promoting the development of cancer.



"What we’ve found is that changes in the cellular concentrations of this critical transcription factor cause specific changes in gene expression patterns, which then contribute to cellular transformation, and a cancer cell phenotype," says Deborah Johnson, Ph.D., professor of molecular pharmacology and toxicology at the USC School of Pharmacy and biochemistry and molecular biology in the Keck School of Medicine.

The first paper, published in Molecular and Cell Biology in May, showed that TBP levels are increased by oncogenic proteins like Ras, one of the first genes found to be involved in human cancers. And that increase, Johnson says, has implications for the development of cancer at the cellular level.


In the cellular production of proteins, the information encoded in DNA is transcribed different types of RNA-ribonucleic acid. This process occurs with the help of enzymes called RNA polymerases. There are three RNA polymerases found in a typical cell, and TATA-binding protein has been shown-by Johnson’s lab and others-to be absolutely critical to the function of all of them.

Because TBP is so central and so basic to the process of transcription, Johnson explains, it was long assumed that its cellular levels remain steady at all times. "It was viewed as a housekeeping protein. Nobody even thought that it could be regulated," she said.

When Johnson questioned that assumption and tried manipulating TBP levels in cells, she found that they could indeed be upregulated-and that the proteins that were especially good at increasing TBP levels were proteins like Ras, which are associated with cancer.

Knowing that oncogenic proteins can raise TBP levels in a laboratory dish was one thing; finding out what happens in a living cell when TBP levels rise was another. "That was the next question we asked," Johnson says. "We wanted to know whether TBP was actually driving Ras to transform normal cells into malignant cells."

In a series of experiments and collaborations with a number of researchers from the Keck School of Medicine, Johnson was able to show that when cells are manipulated so that TBP levels can no longer be increased, Ras is no longer able to transform cells.

And when she increased TBP levels without Ras being present, she found that oncogenesis continued unabated. "In fact," notes Johnson, "we tested it in an animal model, and found that increased TBP alone, without Ras, still leads to tumors in nude mice."

Whether TBP plays a similar role in the development of cancer in humans is something that Johnson is now pursuing in collaboration with USC/Norris Cancer Center pathologist Louis Dubeau, M.D., Ph.D., testing tumor cells for their TBP levels. "If TBP is a true contributor to oncogenesis," Johnson says, "we should see increased TBP levels in a clinically relevant proportion of patients." Preliminary data gathered thus far support this hypothesis.

The second study, published in the June issue of The EMBO Journal (EMBO is the European Molecular Biology Organization), looked at the other side of the oncogenesis coin. "We found in the Molecular and Cellular Biology paper that oncogenes like Ras can increase cellular concentrations of TBP," notes Johnson. "If that’s true, then we might expect tumor suppressors to reduce the level of TBP."

To find out if their expectations were correct, Johnson and her colleagues looked at p53, a tumor suppressor that’s found to be mutated in about half of all human cancers. "P53 keeps cells from growing and proliferating out of control," Johnson says.

Like TBP, p53 is also a transcription factor, regulating expression of the genes involved in cell cycle control and apoptosis, the cellular version of suicide. And previous studies have shown that p53 can bind to TBP. But what the biological relevance of that was had gone unreported, until now.

To determine the relevance, Johnson manipulated the levels of p53 in cells, watching to see what happened with TBP in those cells. What she found was that p53 seems to suppress an important function of TBP, preventing it from working with one of the RNA polymerases. "It’s not changing the cellular concentration of TBP," Johnson explains, "but is instead changing its effective concentration, preventing TBP from forming a complex with other proteins. Forming that complex is essential to TBP’s role in transcribing genes."

These two studies, Johnson points out, are really just complementary parts of a larger picture of the role of TBP in oncogenesis. "With these papers," she says, "we now have two very different scenarios that show that increasing the TBP concentration in a cell leads to that cell’s ability to transform into a tumor cell. And in the second scenario, we have a tumor suppressor that decreases the effective concentration of TBP by altering its ability to function. Together, they both contribute to the ability of the cell to transform from normal to malignant."



Sandra A. S. Johnson, Louis Dubeau, Michael Kawalek, Andrew Dervan, Axel H. Schonthal, Chi V. Dang, Deborah Johnson, "Increased Expression of TATA-Binding Protein, the Central Transcription Factor, Can Contribute to Oncogenesis." Molecular and Cellular Biology, May 2003.

Diane Crighton, Annette Woiwode, Cheng Zhang, Nihar Mandavia, Jennifer P. Morton, Lorna J. Warnock, Jo Milner, Robert J. White, Deborah L. Johnson, "p53 Represses RNA Polymerase III Transcription by Targeting TBP and Inhibiting Promoter Occupancy by TFIIB." The EMBO Journal, June 2, 2003.

Jon Weiner | EurekAlert!
Further information:
http://www.usc.edu/

More articles from Health and Medicine:

nachricht Investigators may unlock mystery of how staph cells dodge the body's immune system
22.09.2017 | Cedars-Sinai Medical Center

nachricht Monitoring the heart's mitochondria to predict cardiac arrest?
21.09.2017 | Boston Children's Hospital

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: The pyrenoid is a carbon-fixing liquid droplet

Plants and algae use the enzyme Rubisco to fix carbon dioxide, removing it from the atmosphere and converting it into biomass. Algae have figured out a way to increase the efficiency of carbon fixation. They gather most of their Rubisco into a ball-shaped microcompartment called the pyrenoid, which they flood with a high local concentration of carbon dioxide. A team of scientists at Princeton University, the Carnegie Institution for Science, Stanford University and the Max Plank Institute of Biochemistry have unravelled the mysteries of how the pyrenoid is assembled. These insights can help to engineer crops that remove more carbon dioxide from the atmosphere while producing more food.

A warming planet

Im Focus: Highly precise wiring in the Cerebral Cortex

Our brains house extremely complex neuronal circuits, whose detailed structures are still largely unknown. This is especially true for the so-called cerebral cortex of mammals, where among other things vision, thoughts or spatial orientation are being computed. Here the rules by which nerve cells are connected to each other are only partly understood. A team of scientists around Moritz Helmstaedter at the Frankfiurt Max Planck Institute for Brain Research and Helene Schmidt (Humboldt University in Berlin) have now discovered a surprisingly precise nerve cell connectivity pattern in the part of the cerebral cortex that is responsible for orienting the individual animal or human in space.

The researchers report online in Nature (Schmidt et al., 2017. Axonal synapse sorting in medial entorhinal cortex, DOI: 10.1038/nature24005) that synapses in...

Im Focus: Tiny lasers from a gallery of whispers

New technique promises tunable laser devices

Whispering gallery mode (WGM) resonators are used to make tiny micro-lasers, sensors, switches, routers and other devices. These tiny structures rely on a...

Im Focus: Ultrafast snapshots of relaxing electrons in solids

Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!

When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...

Im Focus: Quantum Sensors Decipher Magnetic Ordering in a New Semiconducting Material

For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.

Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

“Lasers in Composites Symposium” in Aachen – from Science to Application

19.09.2017 | Event News

I-ESA 2018 – Call for Papers

12.09.2017 | Event News

EMBO at Basel Life, a new conference on current and emerging life science research

06.09.2017 | Event News

 
Latest News

Rainbow colors reveal cell history: Uncovering β-cell heterogeneity

22.09.2017 | Life Sciences

Penn first in world to treat patient with new radiation technology

22.09.2017 | Medical Engineering

Calculating quietness

22.09.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>